Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Mitchel L. Zoler, PhD

Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler

News

siRNA drug safely halved LDL cholesterol in phase 3 ORION-11

Author:
Mitchel L. Zoler, PhD
Publish date: September 4, 2019

PARIS – The new drug inclisiran potently cut LDL cholesterol by inhibiting the PCSK9 enzyme with biannual...

  • Read More

Video

DAPA-HF results transform dapagliflozin from antidiabetic to heart failure drug

Author:
Mitchel L. Zoler, PhD
Publish date: September 2, 2019

PARIS – Proof that dapagliflozin significantly helped heart failure patients without diabetes recategorizes the...

  • Read More

News

FDA’s low-risk TAVR okay set to propel case volume

Author:
Mitchel L. Zoler, PhD
Publish date: August 27, 2019

The FDA’s approval of TAVR for low-risk patients should boost both case numbers and U.S. TAVR sites.

  • Read More

News

Ubrogepant shows acute migraine efficacy in triptan nonresponders

Author:
Mitchel L. Zoler, PhD

PHILADELPHIA – Data from two ubrogepant pivotal trials showed similar migraine pain relief in triptan-ineffective and triptan-effective patients...

  • Read More

News

Asthma hospitalization in kids linked with doubled migraine incidence

Author:
Mitchel L. Zoler, PhD
Publish date: August 14, 2019

PHILADELPHIA – Data from 11 million U.S. pediatric inpatients showed a doubled rate of migraine diagnoses among kids hospitalized for asthma.

  • Read More

Video

Quarterly intravenous eptinezumab prevents migraine

Author:
Mitchel L. Zoler, PhD
Publish date: August 9, 2019

PHILADELPHIA – Results from a pair of dose-ranging, randomized studies showed one IV eptinezumab dose cut migraine recurrences for 3 months.

  • Read More

News

FDA advisors recommend nintedanib for SSc interstitial lung disease

Author:
Mitchel L. Zoler, PhD
Publish date: July 26, 2019

The positive outcome in nintedanib’s pivotal trial and prior FDA approval for idiopathic pulmonary fibrosis swayed panel members.

  • Read More

News

Atogepant shows safety, efficacy for migraine prevention

Author:
Mitchel L. Zoler, PhD

PHILADELPHIA – Atogepant is the first drug from its small-molecule class to undergo advanced clinical testing for migraine prevention.

  • Read More

News

Lymphoma risk prompts FDA recall of Allergan’s textured breast implants

Author:
Mitchel L. Zoler, PhD
Publish date: July 24, 2019

The FDA asked Allergan to recall six brands of textured breast implants and expanders because of the lymphoma risk they pose.

  • Read More

News

Moderately high dietary riboflavin linked to fewer migraines

Author:
Mitchel L. Zoler, PhD
Publish date: July 24, 2019

U.S. NHANES data showed a significant link between moderately high dietary vitamin B2 and fewer...

  • Read More

News

Medication overuse prevalent among U.S. migraine patients

Author:
Mitchel L. Zoler, PhD

PHILADELPHIA – Results from a U.S. survey showed an 18% prevalence of medication overuse among people with self-reported migraine symptoms.

  • Read More

Video

Overreliance on DAS scores undermines rheumatoid arthritis management

Author:
Mitchel L. Zoler, PhD
Publish date: July 15, 2019

MADRID – A rheumatoid arthritis patient says “DAS blindness” now pervades rheumatoid arthritis management and degrades care.

  • Read More

News

Perioperative scripts for migraine abortive drugs linked with fewer pain readmissions

Author:
Mitchel L. Zoler, PhD

PHILADELPHIA - Migraine patients who underwent any surgery and then received a prescription for a migraine abortive drug had fewer 30-day pain...

  • Read More

Video

Telemedicine migraine consults are as effective as in-office visits

Author:
Mitchel L. Zoler, PhD

PHILADELPHIA - Follow-up telemedicine consultations with migraine patients produced outcomes similar to patients managed in office in a randomized...

  • Read More

News

Migraine comorbidities rise with increased headache days

Author:
Mitchel L. Zoler, PhD
Publish date: July 12, 2019

PHILADELPHIA – As the number of migraine headache days per month rises, the prevalence of comorbidities like insomnia and depression also increase...

  • Read More

Pages

  • « first
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2021 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close